These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 8276239)

  • 1. A proteolytic fragment from the central region of p53 has marked sequence-specific DNA-binding activity when generated from wild-type but not from oncogenic mutant p53 protein.
    Bargonetti J; Manfredi JJ; Chen X; Marshak DR; Prives C
    Genes Dev; 1993 Dec; 7(12B):2565-74. PubMed ID: 8276239
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The DNA-binding domain of p53 contains the four conserved regions and the major mutation hot spots.
    Pavletich NP; Chambers KA; Pabo CO
    Genes Dev; 1993 Dec; 7(12B):2556-64. PubMed ID: 8276238
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Site-specific binding of wild-type p53 to cellular DNA is inhibited by SV40 T antigen and mutant p53.
    Bargonetti J; Reynisdóttir I; Friedman PN; Prives C
    Genes Dev; 1992 Oct; 6(10):1886-98. PubMed ID: 1398068
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural basis of restoring sequence-specific DNA binding and transactivation to mutant p53 by suppressor mutations.
    Suad O; Rozenberg H; Brosh R; Diskin-Posner Y; Kessler N; Shimon LJ; Frolow F; Liran A; Rotter V; Shakked Z
    J Mol Biol; 2009 Jan; 385(1):249-65. PubMed ID: 18996393
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discrimination of DNA binding sites by mutant p53 proteins.
    Thukral SK; Lu Y; Blain GC; Harvey TS; Jacobsen VL
    Mol Cell Biol; 1995 Sep; 15(9):5196-202. PubMed ID: 7651437
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A peptide that binds and stabilizes p53 core domain: chaperone strategy for rescue of oncogenic mutants.
    Friedler A; Hansson LO; Veprintsev DB; Freund SM; Rippin TM; Nikolova PV; Proctor MR; Rüdiger S; Fersht AR
    Proc Natl Acad Sci U S A; 2002 Jan; 99(2):937-42. PubMed ID: 11782540
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Grafting of a calcium-binding loop of thermolysin to Bacillus subtilis neutral protease.
    Toma S; Campagnoli S; Margarit I; Gianna R; Grandi G; Bolognesi M; De Filippis V; Fontana A
    Biochemistry; 1991 Jan; 30(1):97-106. PubMed ID: 1899021
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biological significance of a small highly conserved region in the N terminus of the p53 tumour suppressor protein.
    Liu WL; Midgley C; Stephen C; Saville M; Lane DP
    J Mol Biol; 2001 Nov; 313(4):711-31. PubMed ID: 11697899
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A DNA binding domain is contained in the C-terminus of wild type p53 protein.
    Foord OS; Bhattacharya P; Reich Z; Rotter V
    Nucleic Acids Res; 1991 Oct; 19(19):5191-8. PubMed ID: 1923804
    [TBL] [Abstract][Full Text] [Related]  

  • 10. p53 domains: identification and characterization of two autonomous DNA-binding regions.
    Wang Y; Reed M; Wang P; Stenger JE; Mayr G; Anderson ME; Schwedes JF; Tegtmeyer P
    Genes Dev; 1993 Dec; 7(12B):2575-86. PubMed ID: 8276240
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of mutant p53 temperature-sensitive DNA binding.
    Friedlander P; Legros Y; Soussi T; Prives C
    J Biol Chem; 1996 Oct; 271(41):25468-78. PubMed ID: 8810317
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dissociation of DNA binding and in vitro transcriptional activities dependent on the C terminus of P53 proteins.
    Kaku S; Albor A; Kulesz-Martin M
    Biochem Biophys Res Commun; 2001 Jan; 280(1):204-11. PubMed ID: 11162500
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Specific interaction of mutant p53 with regions of matrix attachment region DNA elements (MARs) with a high potential for base-unpairing.
    Will K; Warnecke G; Wiesmüller L; Deppert W
    Proc Natl Acad Sci U S A; 1998 Nov; 95(23):13681-6. PubMed ID: 9811860
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interaction of p53 with its consensus DNA-binding site.
    Wang Y; Schwedes JF; Parks D; Mann K; Tegtmeyer P
    Mol Cell Biol; 1995 Apr; 15(4):2157-65. PubMed ID: 7891710
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Loss of transactivation and transrepression function, and not RPA binding, alters growth suppression by p53.
    Leiter LM; Chen J; Marathe T; Tanaka M; Dutta A
    Oncogene; 1996 Jun; 12(12):2661-8. PubMed ID: 8700525
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The C-terminal domain of p53 recognizes DNA damaged by ionizing radiation.
    Reed M; Woelker B; Wang P; Wang Y; Anderson ME; Tegtmeyer P
    Proc Natl Acad Sci U S A; 1995 Oct; 92(21):9455-9. PubMed ID: 7568153
    [TBL] [Abstract][Full Text] [Related]  

  • 17. p53 Latency. C-terminal domain prevents binding of p53 core to target but not to nonspecific DNA sequences.
    Yakovleva T; Pramanik A; Kawasaki T; Tan-No K; Gileva I; Lindegren H; Langel U; Ekstrom TJ; Rigler R; Terenius L; Bakalkin G
    J Biol Chem; 2001 May; 276(19):15650-8. PubMed ID: 11279079
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interaction with damaged DNA induces selective proteolytic cleavage of p53 to yield 40 kDa and 35 kDa fragments competent for sequence-specific DNA binding.
    Molinari M; Okorokov AL; Milner J
    Oncogene; 1996 Nov; 13(10):2077-86. PubMed ID: 8950974
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The carboxyl-terminal domain of the p53 protein regulates sequence-specific DNA binding through its nonspecific nucleic acid-binding activity.
    Bayle JH; Elenbaas B; Levine AJ
    Proc Natl Acad Sci U S A; 1995 Jun; 92(12):5729-33. PubMed ID: 7777576
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reactivation of mutant p53 through interaction of a C-terminal peptide with the core domain.
    Selivanova G; Ryabchenko L; Jansson E; Iotsova V; Wiman KG
    Mol Cell Biol; 1999 May; 19(5):3395-402. PubMed ID: 10207063
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.